Other languages Syncona Limited

Equities

Delayed London S.E. Other stock markets 11:52:40 13/06/2024 BST			5-day change	1st Jan Change
109 ^GBX	+0.55%		-0.37%	-11.67%

05-17	Syncona notes Autolus's first quarter loss widens amid higher costs	AN
05-09	Syncona's Freeline gets positive results for Gaucher disease	AN

Syncona notes Autolus's first quarter loss widens amid higher costs	05-17
Syncona's Freeline gets positive results for Gaucher disease	05-09
Jefferies cuts AJ Bell; Deutsche likes ConvaTec	05-03
Syncona agrees to sell stake in investee company for GBP7.4 million	04-11
Syncona to Sell Stake in Portfolio Company to Century Therapeutics	04-11
Syncona notes investee Achilles's annual loss narrows	04-04
Syncona portfolio company Autolus posts widened loss for 2023	03-14
Syncona’s Takeover of Freeline Therapeutics Becomes Effective	02-20
Freeline shareholders approve Syncona acquisition	02-12
Freeline Therapeutics' Shareholders Approve Acquisition by Syncona	02-12
Syncona portfolio strengthens in third quarter thanks to Autolus	02-08
Syncona's Fiscal Q3 NAV Declines	02-08
Syncona notes FDA acceptance of Autolus's BLA for obe-cel	01-22
Syncona says Freeline trial for Gaucher disease treatment positive	01-19
Pharma und Gesundheit: weitere Konsolidierung	12-13
Farma en gezondheid: consolidatie gaat door	12-12
Farmaceutica e salute: continua il consolidamento	12-11
Farmacia y salud: La consolidación continúa	12-11
Pharma & santé : poursuite de la consolidation	12-11
Syncona notes Beacon's "encouraging" AGTC-501 trial data	12-04

No results for this search